Clinical trials
Glioblastoma trials in Israel
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 2 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 2 |
| 2023 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
| Unknown status | 6 |
| Terminated | 5 |
| Active, not recruiting | 2 |
| Suspended | 1 |
| Recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 6 |
| NovoCure Ltd. | 4 |
| AbbVie | 2 |
| INSYS Therapeutics Inc | 2 |
| Sheba Medical Center | 2 |
| Tel-Aviv Sourasky Medical Center | 2 |
| Vascular Biogenics Ltd. operating as VBL Therapeutics | 2 |
| Celldex Therapeutics | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Hadassah Medical Organization | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioblastoma | 35 |
| Brain Neoplasms | 8 |
| Astrocytoma | 6 |
| Glioma | 5 |
| Gliosarcoma | 5 |
| Neoplasms | 5 |
| Recurrence | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Central Nervous System Neoplasms | 2 |
| Ganglioglioma | 2 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.